Lovell, nCAP Medical partner to expand NeuroCuple access in federal healthcare

Lovell Government Services and nCAP Medical are partnering to broaden access to NeuroCuple, a reusable, drug-free pain relief technology, across VA, military and Indian Health Service settings. The deal is meant to give federal providers a simpler contracting path while supporting SDVOSB procurement goals.

Why it matters: - The partnership could make a non-drug pain relief option easier to buy for Veterans Health Administration, Military Health System and Indian Health Service providers. - The arrangement may help federal agencies meet Service-Disabled Veteran-Owned Small Business procurement goals while streamlining acquisition. - nCAP Medical’s NeuroCuple is positioned as a reusable alternative for acute and chronic pain management in clinical, training and field settings.

What happened: - Lovell Government Services and nCAP Medical announced a partnership on Sept. 24, 2026, to expand access to NeuroCuple across federal healthcare systems. - The agreement covers federal healthcare providers serving Veterans, service members and other beneficiaries. - Lovell will serve as nCAP Medical’s Service-Disabled Veteran-Owned Small Business vendor.

The details: - NeuroCuple is a reusable, drug-free, non-invasive pain relief technology built on nCAP Medical’s patented Neuro Capacitive technology. - The device is designed to sit over or near an area of pain and passively interact through capacitive coupling with naturally occurring bioelectric activity associated with pain. - The technology is designed to reduce pain without delivering electrical stimulation, medication or other active energy into the body. - NeuroCuple devices require no batteries, charging, wires or external power. - The devices can be used on the body or over clothing and dressings. - The compact, lightweight design is intended to support immediate use in training, operational and field environments. - nCAP Medical products are pending addition to, or available through, Lovell’s federal contract vehicles, including the Department of Veterans Affairs Federal Supply Schedule, GSA Advantage, the Defense Logistics Agency’s Electronic Catalog and the Department of Defense’s Distribution and Pricing Agreement. - Lovell says availability through established federal contract vehicles can simplify buying for agencies. - Lovell says the channel can also support agency SDVOSB procurement goals. - NeuroCuple has been clinically studied in orthopedic surgical patients, including total knee arthroplasty, with research evaluating pain relief, opioid use and recovery. - nCAP Medical says its technology has reached users worldwide through its own products and licensing partnerships.

Between the lines: - The partnership links a pain-management product with a veteran-owned federal contracting specialist, which is often the fastest route into government healthcare systems. - The pitch centers on portability, zero-power use and drug-free pain relief, which aligns with growing interest in non-opioid options. - The announcement also extends nCAP Medical’s strategy beyond direct sales into federal distribution channels.

What's next: - nCAP Medical products are expected to move through Lovell’s federal contract vehicles as the addition process is completed. - Federal providers could gain a more direct procurement path for NeuroCuple if the listings progress as planned. - The companies said the partnership is aimed at broadening access for Veterans, service members and federal healthcare professionals.

The bottom line: - The deal gives NeuroCuple a clearer path into federal healthcare procurement, where contracting access can matter as much as product design.